From cardiac ablation devices to OTC glucose sensors, explore how breakthrough medical technologies are disrupting ...

The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Upwards of 1,000 HHS employees were affected. However, the department has rolled back some of the layoffs at the CDC, where ...

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...